Results

Total Results: 1,544 records

Showing results for "drug".

  1. effectivehealthcare.ahrq.gov/sites/default/files/methodsguidenorris_060420101.pdf
    June 01, 2010 - a class switch to a different drug in the same class. … Food and Drug Administration and the Center for Medicare and Medicaid Services. … Challenges and opportunities for pharmacoepidemiology in drug-therapy decision making. … Drug Effectiveness Review Project. … Drug class review on the triptans: Drug Effectiveness Review Project.
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-observational-studies_methods.pdf
    June 01, 2010 - a class switch to a different drug in the same class. … Food and Drug Administration and the Center for Medicare and Medicaid Services. … Challenges and opportunities for pharmacoepidemiology in drug-therapy decision making. … Drug Effectiveness Review Project. … Drug class review on the triptans: Drug Effectiveness Review Project.
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/back-pain-treatment_clinician.pdf
    November 01, 2016 - versus placebo; ↔ = no difference between the interventions; NSAID = nonsteroidal anti-inflammatory drug … versus placebo; ↔ = no difference between the interventions; NSAID = nonsteroidal anti-inflammatory drug … not be ruled out. �» Clinicians are advised to refer to individual studies in the report or to the drug … labels of each drug for comprehensive information on their potential adverse effects. … difference between the interventions; EMG = electromyography; NSAID = nonsteroidal anti-inflammatory drug
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/insomnia_clinician.pdf
    August 01, 2017 - Food and Drug Administration (FDA) has approved several prescription drugs for insomnia, typically … Drug General Adult Population Adults 55 Years of Age and Older Global Outcomes Sleep Outcomesa Global … Food and Drug Administration (FDA) for insomnia. d Other benzodiazepines include drugs approved by … Food and Drug Administration Label Information Drug Class Drug Common Effectsa Serious Effectsb Nonbenzo … insomnia, nausea �� Potential impairment of activities requiring complete mental alertness after drug
  5. effectivehealthcare.ahrq.gov/sites/default/files/09_infectiousdisease_potential_high_impact_june_2012.pdf
    January 01, 2012 - coverage and formulary status of the drug on the patient’s drug plan … Drug coverage guidelines. [internet]. … Food and Drug Administration (FDA); 2011 Apr 5. … Anthem Blue Cross California drug list. … Drug list search results: Dificid. [internet].
  6. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_executive.pdf
    September 01, 2011 - Food and Drug Administration (FDA) recently placed a box warning on the entire class of biologic DMARDs … Health Assessment Questionnaire; CI = confidence interval; DMARD(s) = disease-modifying anti-rheumatic drug
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/suicidal-thoughts-young-people-appendix-a.pdf
    September 26, 2023 - .ti,ab,kf. 5 1 or 2 or 3 or 4 6 Therapeutics/ 7 (dm or dt or th).fs. 8 exp Psychotherapy/ 9 Drug … therap*" or "dialectical behavioural therap*" or Digital or dimethyltryptamine or DMT or doximity or drug … therap*" OR "dialectical behavioural therap*" OR Digital OR dimethyltryptamine OR DMT OR doximity OR drug
  8. S66 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s66.pdf
    October 01, 2007 - Reform of drug regulation—beyond an indepen- dent drug-safety board. … The epidemiology of drug treatment failure in rheumatoid arthritis. … Phar- macoepidemiol Drug Saf. 2006;15:565–574. 20. Steiner JF, Earnest MA. … Coding accuracy of administra- tive drug claims in the Ontario Drug Benefit database. … Trends in prescription drug expenditures by Medicaid enrollees.
  9. effectivehealthcare.ahrq.gov/products/arthritis-psoriatric/research
  10. effectivehealthcare.ahrq.gov/sites/default/files/functional-limitations-horizon-scan-high-impact-1306.pdf
    June 01, 2013 - , the drug may be cost saving. … MS drug under investigation after 11 deaths. In: Drug Discovery & Development [internet]. … Anthem Blue Cross California drug list. … Specialty pharmacy program drug list. … Food and Drug Administration (FDA).
  11. S158 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s158.pdf
    October 01, 2007 - DrPH,*§¶ Jerry Avorn, MD,* and Sebastian Schneeweiss, MD*� Background: Nonexperimental studies of drug … effects in large automated databases can provide timely assessment of real-life drug use, but are prone … Paradoxical relations of drug treatment with mortality in older persons. … Colorectal cancer after start of nonsteroidal anti-inflammatory drug use. … Pharmacoepidemiol Drug Saf. 2006;15:291–303. 10. Angrist JD, Imbens GW, Rubin DB.
  12. PEPTIC ULCER #11 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - Food and Drug Administration (FDA) approval was based reported that patients with SBS experienced a … Food and Drug Administration (FDA). FDA approves Gattex to treat short bowel syndrome. … Food and Drug Administration (FDA); 2012 Dec 21 [accessed 2013 Jun 05]. [2 p]. … Specialty drug list. [internet]. … Drug coverage guidelines search: Gattex. [internet].
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/antidepressants-update_disposition-comments.pdf
    December 01, 2011 - It would be better if it could be divided into 2 reports - one way to do this would be drug vs drug … Peer Reviewer #5 Methods Pg. 33, line 28 “…and drug interactions.” … 'Drug Interactions' is not really an outcome measure. … or page 49, line 37-57 Direct evidence was considered sufficient to conduct meta- analyses for six drug-drug … Might want to say that this is probably only possible with this specific drug.
  14. PEPTIC ULCER #11 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1512.pdf
    December 01, 2015 - Food and Drug Administration (FDA); 2014 Nov 19. 2 p. … Food and Drug Administration (FDA); 2014 Nov 19. 3 p. … Food and Drug Administration; 1993 Nov 19 [accessed 2015 Sep 11]. [2 p]. … Food and Drug Administration (FDA); 1 p. … Food and Drug Administration; 1992 Nov 24 [accessed 2015 Sep 11]. [2 p].
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/insomnia_disposition-comments.pdf
    December 30, 2015 - Once a drug is out of patent there is no incentive to finance proper modern studies. … We included any drug available in the United States if there were eligible trials. … ‘As needed’ use made insomnia WORSE on nights the drug was omitted. … on nights the drug is not taken. … and the placebo group after drug withdrawal.
  16. effectivehealthcare.ahrq.gov/sites/default/files/08_functional_limitations_potential_high_impact_2012-12-10.pdf
    January 01, 2012 - syringes of the drug at no cost. … MS drug under investigation after 11 deaths. In: Drug Discovery & Development [internet]. … Specialty pharmacy program drug list. … MAP Pharmaceuticals resubmits New Drug Application to FDA for Levadex orally inhaled migraine drug … Food and Drug Administration (FDA).
  17. effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1512.pdf
    December 01, 2015 - Food and Drug Administration (FDA). … Food and Drug Administration (FDA). 510(k) summary for Raisin personal monitor [K093976]. … Food and Drug Administration (FDA); 2010 Mar 25 [accessed 2010 Dec 27]. [10 p]. … Food and Drug Administration (FDA); 2012 May 14. 10 p. … FDA accepts first digital medicine New Drug Application for Otsuka and Proteus Digital Health.
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/pilot-projects-supplementing-white-paper.pdf
    December 01, 2024 - and Drug Holiday for Osteoporosis Fracture Prevention9 Improve applicability of evidence*; … Benefits and harms of drug treatments. BMJ. 2004 Jul 3;329(7456):2-3. … Long- Term Drug Therapy and Drug Holidays for Osteoporosis Fracture Prevention: A Systematic Review … Long- Term Drug Therapy and Drug Discontinuations and Holidays for Osteoporosis Fracture Prevention … Should pregnant women be included in phase IV clinical drug trials?
  19. effectivehealthcare.ahrq.gov/sites/default/files/ch_1-user-guide-to-ocer_130129.pdf
    August 13, 2012 - submits an application to the FDA for an “investigational new drug.” … in routine clinical care after the drug is approved for marketing (phase 4). … Intervention What is the intervention of interest (e.g., a drug, device, procedure, or test)? … Coverage Which bisphosphonate drugs should be included on a drug formulary? … Pharmacoepidemiol Drug Saf. 2012 May; 21 Suppl 2:6-12. 12. Normand SL, McNeil BJ.
  20. effectivehealthcare.ahrq.gov/products/mhs4-computerized-cds/rapid-research

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: